06 mar 2015
Gene Alterations in Melanoma May Predict Immunotherapy Outcomes
Among patients with melanoma who were treated with immunotherapies, those whose tumours had mutations in the gene NRAS had better response and treatment outcomes than those whose tumours did not have NRAS mutations
